Innovator U.S. Equity Accelerated Plus ETF – April (XTAP) is an exchange-traded fund that provides accelerated exposure to the price return of the S&P 500 Index, subject to a cap, over a one-year outcome period ending in April. The fund employs a FLEX Option strategy, utilizing standardized exchange-traded options in combination with FLEX options issued by the Options Clearing Corporation, to achieve 2.5 to 3.5 times (2.5x-3.5x) the upside performance of the underlying index, net of fees, while offering limited downside protection before the cap is applied; it resets its outcome period annually in April and is actively managed by Innovator ETFs, part of Innovator Capital Management, LLC. The ETF targets sophisticated investors seeking defined outcome investment strategies in the U.S. large-cap equity segment and operates exclusively in the United States, listed on the Cboe BZX Exchange under the ticker XTAP.
Innovator Capital Management, headquartered in Elmwood Park, New Jersey, and founded in 2015, serves as the sponsor and investment adviser, offering a suite of defined outcome ETFs including the Power Buffer series, Ultra Buffer series, and Accelerated series across various outcome periods (e.g., 9-month, 12-month) and leverage multiples (e.g., 2x, 3x), with XTAP specifically focusing on April-period accelerated upside in U.S. equities; the firm does not have notable subsidiaries but collaborates with counterparties for options execution. Recent developments include the launch of additional accelerated ETFs in the series during 2024, expanding the product lineup to include more granular outcome periods and enhanced leverage options amid growing demand for structured equity exposure; in late 2024, Innovator announced strategic enhancements to its options framework to improve cap potential and efficiency, alongside increased assets under management surpassing $10 billion firm-wide as of mid-2025, reflecting robust inflows into defined outcome products. No major acquisitions, partnerships, or reorganizations have been reported for Innovator or XTAP in the past 1-2 years.